Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on ...

ALL-INCLUSIVES have long been a go-to for many holidaymakers venturing to Turkey. Eating and drinking as much as you want is ...

Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with ...

In a major step toward a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for ...

Scientists unlock the mechanism behind C. diff’s most harmful toxin, opening the door to more targeted treatments that protect gut health and prevent disease recurrence.

Evidence suggests the composition of the gut microbiome modulates a tumor’s response to therapy. Maat Pharma SA has thus developed Microbiome Ecosystem Therapies (METs) that replicate, at a large ...